267 related articles for article (PubMed ID: 36619561)
1. Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review.
Alqarni S; Alsebai M
Front Endocrinol (Lausanne); 2022; 13():1032192. PubMed ID: 36619561
[TBL] [Abstract][Full Text] [Related]
2. VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases.
Quinn JP; Kandigian SE; Trombetta BA; Arnold SE; Carlyle BC
Brain Commun; 2021; 3(4):fcab261. PubMed ID: 34778762
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Chen X; Hu Y; Cao Z; Liu Q; Cheng Y
Front Immunol; 2018; 9():2122. PubMed ID: 30283455
[TBL] [Abstract][Full Text] [Related]
4. Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.
Sun J; Ludvigsson JF; Ingre C; Piehl F; Wirdefeldt K; Zagai U; Ye W; Fang F
PLoS Med; 2022 Sep; 19(9):e1004092. PubMed ID: 36107840
[TBL] [Abstract][Full Text] [Related]
5. CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis.
Agah E; Saleh F; Sanjari Moghaddam H; Saghazadeh A; Tafakhori A; Rezaei N
Syst Rev; 2018 Dec; 7(1):237. PubMed ID: 30572951
[TBL] [Abstract][Full Text] [Related]
6. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
[TBL] [Abstract][Full Text] [Related]
7. CSF peptides from VGF and other markers enhance prediction of MCI to AD progression using the ATN framework.
Llano DA; Devanarayan P; Devanarayan V;
Neurobiol Aging; 2023 Jan; 121():15-27. PubMed ID: 36368195
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide VGF-Derived Peptide LQEQ-19 has Neuroprotective Effects in an In Vitro Model of Amyotrophic Lateral Sclerosis.
Noda Y; Motoyama S; Nakamura S; Shimazawa M; Hara H
Neurochem Res; 2019 Apr; 44(4):897-904. PubMed ID: 30656593
[TBL] [Abstract][Full Text] [Related]
9. Pseudobulbar affect in neurodegenerative diseases: A systematic review and meta-analysis.
Nabizadeh F; Nikfarjam M; Azami M; Sharifkazemi H; Sodeifian F
J Clin Neurosci; 2022 Jun; 100():100-107. PubMed ID: 35436682
[TBL] [Abstract][Full Text] [Related]
10. Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis.
Zhao Z; Lange DJ; Ho L; Bonini S; Shao B; Salton SR; Thomas S; Pasinetti GM
Int J Med Sci; 2008 Apr; 5(2):92-9. PubMed ID: 18432310
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for Managing Neurodegenerative Diseases.
Cheslow L; Snook AE; Waldman SA
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672416
[TBL] [Abstract][Full Text] [Related]
12. Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis.
Lanznaster D; Hergesheimer RC; Bakkouche SE; Beltran S; Vourc'h P; Andres CR; Dufour-Rainfray D; Corcia P; Blasco H
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326346
[TBL] [Abstract][Full Text] [Related]
13. VGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model Studies.
Brancia C; Noli B; Boido M; Boi A; Puddu R; Borghero G; Marrosu F; Bongioanni P; Orrù S; Manconi B; D'Amato F; Messana I; Vincenzoni F; Vercelli A; Ferri GL; Cocco C
PLoS One; 2016; 11(10):e0164689. PubMed ID: 27737014
[TBL] [Abstract][Full Text] [Related]
14. Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review.
Nicoletti A; Baschi R; Cicero CE; Iacono S; Re VL; Luca A; Schirò G; Monastero R;
Mech Ageing Dev; 2023 Jun; 212():111821. PubMed ID: 37127082
[TBL] [Abstract][Full Text] [Related]
15. Blood-Based Transcriptomic Biomarkers Are Predictive of Neurodegeneration Rather Than Alzheimer's Disease.
Shvetcov A; Thomson S; Spathos J; Cho AN; Wilkins HM; Andrews SJ; Delerue F; Couttas TA; Issar JK; Isik F; Kaur S; Drummond E; Dobson-Stone C; Duffy SL; Rogers NM; Catchpoole D; Gold WA; Swerdlow RH; Brown DA; Finney CA
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834458
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic clocks in neurodegenerative diseases: a systematic review.
Yang T; Xiao Y; Cheng Y; Huang J; Wei Q; Li C; Shang H
J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):1064-1070. PubMed ID: 36963821
[TBL] [Abstract][Full Text] [Related]
18. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
[TBL] [Abstract][Full Text] [Related]
19. Association of Selenium Levels with Neurodegenerative Disease: A Systemic Review and Meta-Analysis.
Zhou J; Zhang W; Cao Z; Lian S; Li J; Nie J; Huang Y; Zhao K; He J; Liu C
Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686737
[TBL] [Abstract][Full Text] [Related]
20. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.
Lill CM; Rengmark A; Pihlstrøm L; Fogh I; Shatunov A; Sleiman PM; Wang LS; Liu T; Lassen CF; Meissner E; Alexopoulos P; Calvo A; Chio A; Dizdar N; Faltraco F; Forsgren L; Kirchheiner J; Kurz A; Larsen JP; Liebsch M; Linder J; Morrison KE; Nissbrandt H; Otto M; Pahnke J; Partch A; Restagno G; Rujescu D; Schnack C; Shaw CE; Shaw PJ; Tumani H; Tysnes OB; Valladares O; Silani V; van den Berg LH; van Rheenen W; Veldink JH; Lindenberger U; Steinhagen-Thiessen E; ; Teipel S; Perneczky R; Hakonarson H; Hampel H; von Arnim CAF; Olsen JH; Van Deerlin VM; Al-Chalabi A; Toft M; Ritz B; Bertram L
Alzheimers Dement; 2015 Dec; 11(12):1407-1416. PubMed ID: 25936935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
